Biotech companies often pin their products’ market hopes on one of two strategies. On one hand, licensing to another pharmaceutical company may offer immediate commercial muscle but hands over control to a partner that may not share long-term interests. On the other hand, building a commercial infrastructure from scratch can allow you to retain full ownership but entails considerable time and operational risk.

Quintiles’ launch solutions allow you to maintain strategic direction of your asset while maximising its commercial potential. With a comprehensive range of proven commercial services, the company can tailor a solution to help launch your product, portfolio or company in any global market.